Ikris Pharma
FDA Granted Approval of Selinexor Triplet for Refractory/Relapsed Multiple Myeloma
On December 18'th, 2020, the FDA granted approval to selinexor along with bortezomib and dexamethasone in order to treat adult patients...
top of page
IKRIS PHARMA
Home: Welcome
Search
Home: Blog2
Home: Subscribe
bottom of page